血防846、7505合并治疗肝吸虫病疗效观察

• 作 者: 张玉兰
• 机 构: 重庆市沙坪坝区卫生防疫站
• 出 处: 新药与临床
• 发表日期: 1984年05期
• 关键词: 肝吸虫病 合并治疗 阴转率 滴丸 日组 白细胞增高 黄疸 超声波检查 临床观察 较好

本文报道了单用血防846、7505合并血防846口服治疗72例肝吸虫病患者的疗效对比观察,经用醛醚法考核,各药物组均有一定疗效。以7505 0.61mg/(kg·d)合并血防846 35mg/(kg·d)5日组疗效较好.1月后阴转率为67％,3月后阴转率为79％,副反应比其他组稍重,未见黄疸及发热者,但在今后的治疗工作中仍应警惕。

This article reports the efficacy of monotherapy with anti-846,7505 combined with blood-serum 846 orally in the treatment of 72 patients with hepatic detritivitis. The results of aldosteron test showed that each drug group had a certain curative effect. The combination of 7505 0.61mg / (kg · d) blood group 846 35mg / (kg · d) on the 5th day was better.After January, the negative conversion rate was 67%, the negative conversion rate was 79% after March, the side reaction ratio Other groups slightly heavier, no jaundice and fever, but in the future treatment should be vigilant.